509: Two scenarios where asymptomatic bacteriuria is treated in adult patients without symptoms
507: Why can’t you use the Naranjo algorithm in the setting of drug overdose?
506: The pharmacist’s role if malignant hyperthermia is suspected outside of the operating room
505: New observational data on hydroxychloroquine and Covid-19
504: Can the dose of enoxaparin for VTE prophylaxis be reduced in low weight patients?
503: Safety of IV push antibiotics
Episode 502: Azithromycin vs. levofloxacin for legionella pneumonia
501: Highlights of the remdesivir emergency use prescribing information
500: Is this Tamiflu 2.0?
499: What is the Clinical Effectiveness of PCC in Factor Xa Inhibitor-Related Intracranial Hemorrhage?
498: NIH Guidelines on Therapeutic Options for COVID-19
- « Previous Page
- 1
- …
- 49
- 50
- 51
- 52
- 53
- …
- 93
- Next Page »